REMD Biotherapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch REMD Biotherapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus (NCT03117998) | REMD Biotherapeutics, Inc. | 2017-09-19 |
Track REMD Biotherapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.